Correlation Between Day One and Larimar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Day One and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Larimar Therapeutics, you can compare the effects of market volatilities on Day One and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Larimar Therapeutics.

Diversification Opportunities for Day One and Larimar Therapeutics

0.76

Correlation Coefficient

Day One  Larimar Therapeutics

Poor diversification

The 3 months correlation between Day and Larimar is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Day One i.e., Day One and Larimar Therapeutics go up and down completely randomly.

Pair Corralation between Day One and Larimar Therapeutics

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.45 times more return on investment than Larimar Therapeutics. However, Day One Biopharmaceuticals is 2.21 times less risky than Larimar Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  1,350  in Day One Biopharmaceuticals on September 2, 2024 and sell it today you would earn a total of  43.00  from holding Day One Biopharmaceuticals or generate 3.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Larimar Therapeutics

Day One Biopharmaceu

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Larimar Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Larimar Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Day One and Larimar Therapeutics

The main advantage of trading using opposite Day One and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.

The idea behind Day One Biopharmaceuticals and Larimar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.